Sanjay Shrestha was named Chief Executive Officer of Health In Tech, Inc. As of November 6, 2026, Health In Tech, Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from May 1, 2026 to October 26, 2026, naming 1 appointment (Form 8-K, October 26, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Health In Tech, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Health In Tech, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-05-01 to 2026-10-26. They name 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Health In Tech, Inc. files it.
Also on the record for Health In Tech, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 29, 2026 | Stake report, Schedule 13G, by LYTTON LAURENCE W | 6.2% of the class | 5%+ stakes | Source |
| December 23, 2024 | IPO filing, Form 424B4 | $4 a share | IPO filings | Source |
| December 17, 2024 | IPO filing, Form S-1/A | — | IPO filings | Source |
| November 19, 2024 | IPO filing, Form S-1/A | $4 to $5 a share | IPO filings | Source |
| November 6, 2024 | IPO filing, Form S-1/A | $4 to $5 a share | IPO filings | Source |
| October 11, 2024 | IPO filing, Form S-1/A | — | IPO filings | Source |
| October 3, 2024 | IPO filing, Form S-1/A | $4 to $5 a share | IPO filings | Source |
| September 24, 2024 | IPO filing, Form S-1/A | $4 to $5 a share | IPO filings | Source |
| August 30, 2024 | IPO filing, Form S-1 | $4 to $5 a share | IPO filings | Source |
Selling to them or working with them? See who runs Health In Tech, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Health In Tech, Inc. and the records around it.
Health In Tech, Inc. elsewhere on the record
Companies that share a holder
- LYTTON LAURENCE W also filed stake reports on 28 other companies: Retension Pharmaceuticals, Inc. (Oct 2026), Rank One Computing Corp (Aug 2026), MDxHealth SA (Aug 2026)
Watch Health In Tech, Inc.
Get an email when Health In Tech, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Health In Tech, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Health In Tech, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Health In Tech, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-10-26 | In | Chief Executive Officer | 8-K, 2026-10-26 | ||
| 2026-05-01 | Reported | not named in the filing | 8-K, 2026-05-01 |
Who leads Health In Tech, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Executive Officer: Sanjay Shrestha, appointed (filed 2026-10-26).
New leaders reset buying decisions — get the Full Report on Health In Tech, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Executive Officer at Health In Tech, Inc., with the record behind each one.
Find candidates like Chief Executive Officer at Health In Tech, Inc.Every change, in the filing's words
Appointed: Sanjay Shrestha, Chief Executive Officer
On October 20, 2026, the Board of Directors (the "Board") of Health In Tech, Inc. (the "Company" or "Health In Tech") appointed Sanjay Shrestha to serve as the Chief Executive Officer of the Company, effective as of such date (the "Effective Date").
- Mr. Shrestha succeeds Tim Johnson, the Company's founder, who ceased serving as Chief Executive Officer of the Company and transitioned to his new role as Executive Chairman of the Board on the same date.
- Mr. Johnson's transition from the role of Chief Executive Officer was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
- Mr. Shrestha, age 52, previously served as an independent director of the Board and on the Audit Committee, the Nominating and Governance Committee and the Compensation Committee of the Board from April 2025 until his resignation in August 2026, and he thereafter has served as Strategic Advisor to the Board since September 2026.
- Previously, Mr. Shrestha served until October 2025 as President of Plug Power, Inc. (Nasdaq: PLUG), where he held senior leadership responsibilities, including oversight of business expansion, strategic investments, corporate development and capital markets initiatives, following his appointment there as Chief Strategy Officer in 2019.
- Earlier in his career, Mr. Shrestha held leadership roles in investing, investment banking and equity research, including as Global Head of Renewables Research at Lazard Capital Markets, and at First Albany Capital, where he built the renewables and industrial research practice.
Reported
Following receipt of formal notice on April 27, 2026, Dustin Plantholt departed from his role as Chief AI & Marketing Officer of Health In Tech, Inc. (the "Company"), effective as of April 30, 2026, as part of a business transition and not as a result of any disagreement with the Company on any matter relating to its operations, policies or practices.
- The Consulting Agreement can be terminated by either party upon ten (10) days' prior written notice.
Tools for this story
Each opens in a new tab, filled in for Health In Tech, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.